Metformin is an oral anti-diabetic drug in the biguanide class. It is the first-line drug of choice for the treatment of type 2 diabetes, particularly in overweight and obese people and those with normal kidney function.
Metformin is indicated as an adjunct to diet and exercise to lower blood glucose in patients with type 2 diabetes when diet and exercise do not result in adequate glycemic control.
– Metformin is indicated in audult as either monotherapy or in combination therapy with other antidiabetic drugs or insulin.
– Metformin is indicated for decreasing diabetes-related complications in overweight patients with type 2 diabetes after a diet treatment has failed.
Subject to medical prescription
Pharmaceutical form: 850 mg x 30 film-coated tablets
NHIF code: AF 341 ICD: E11.2, E11.3, E11.4, E11.5, E11.9